SGLT2 INHIBITION IN KIDNEY TRANSPLANT RECIPIENTS WITH DIABETES

被引：0
|
作者：
Guthoff, M. [1 ]
Mahling, M. [1 ]
Nadalin, S. [2 ]
Heyne, N. [1 ]
机构：
[1] Sekt Nieren & Hochdruckkrankheiten, Med Klin 4, Tubingen, Germany
[2] Univ Klin Allgemeine Viszeral & Transplantat Chir, Tubingen, Germany
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P22
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [31] SGLT2 Inhibitor, an Agent for Diabetes, Heart, Kidney ... and Stroke
    Yang, Taeil
    Lee, Jooyeon
    Oh, Jaewon
    KOREAN CIRCULATION JOURNAL, 2024, 54 (09) : 562 - 564
  • [32] Mechanistic effects of SGLT2 inhibition on blood pressure in diabetes
    Yaribeygi, Habib
    Atkin, Stephen L.
    Sahebkar, Amirhossein
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) : 1679 - 1683
  • [33] SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
    Ele Ferrannini
    Anna Solini
    Nature Reviews Endocrinology, 2012, 8 : 495 - 502
  • [34] SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
    Ferrannini, Ele
    Solini, Anna
    NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (08) : 495 - 502
  • [35] The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
    Oe, Yuji
    Vallon, Volker
    KIDNEY AND DIALYSIS, 2022, 2 (02): : 349 - 368
  • [36] A Novel Potential of SGLT2 Inhibition: Antifibrotic Effect in Diabetes
    Balogh, Dora
    Hodrea, Judit
    Hosszu, Adam
    Lenart, Lilla
    Lakat, Tamas
    Saeed, Adar
    Rimaszombati, Fruzsina
    Wagner, Laszlo
    Szabo, Attila
    Fekete, Andrea
    FASEB JOURNAL, 2020, 34
  • [37] RENOPROTECTION WITH SGLT2 INHIBITION
    Komala, M. G.
    Gross, S.
    Pegg, K.
    Huang, C.
    Chen, J.
    Mather, A.
    Pollock, C.
    Panchapakesan, U.
    NEPHROLOGY, 2013, 18 : 56 - 56
  • [38] SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1879 - 1904
  • [39] RENOPROTECTION WITH SGLT2 INHIBITION
    Panchapakesan, U.
    Forbes, J.
    Pegg, K.
    Mudaliar, H.
    Pollock, C.
    Mather, A.
    NEPHROLOGY, 2011, 16 : 33 - 33
  • [40] Safety of SGLT2 Inhibitors in Kidney Transplant Recipients with Type 2 Diabetes Mellitus (T2DM) or New-Onset Diabetes after Transplant (NODAT): A Single-Centre Experience
    Hamza, Wigdan
    Moqeem, Komal
    Riaz, Aisha
    Moore, Natasha Aj
    Asgari, Elham
    Dudreuilh, Caroline
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345